用于治疗酒精使用障碍的药物:叙事审查
Henry R Kranzler1,2, Emily E Hartwell1,2
1Department of Psychiatry, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Alcohol, clinical & experimental research
|August 1, 2023
概括
对酒精使用障碍 (AUD) 的药物使用不足. 像纳尔特雷和托皮拉这样的阿片类药物对抗剂在减少饮酒频率和重度饮酒方面表现一致,提供有效的药物治疗选择.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
背景情况:
- 长期重度饮酒会影响神经递质系统,导致医疗,精神和社会问题.
- 对酒精使用障碍 (AUD) 的基于证据的药物在临床实践中未得到充分利用.
- 最佳使用AUD药物,包括剂量,持续时间和组合,需要进一步调查.
研究的目的:
- 审查FDA批准和非标签药物用于AUD治疗的证据.
- 讨论AUD药物治疗的作用机制,临床使用和药物遗传学发现.
- 提供治疗建议,并建议AUD药物治疗的未来研究方向.
主要方法:
- 关于AUD药物治疗的科学文献的叙事综述.
- 对已批准的药物 (迪苏尔菲拉姆,纳尔特雷,阿坎普罗沙特) 和常用的非标签药物 (加巴丁,巴克洛芬,托皮拉马特) 的分析.
- 对药物机制,临床疗效,药物遗传学和治疗指南的评估.
主要成果:
- 纳尔特雷和托皮拉在减少饮酒频率和重度饮酒方面表现出一致的小到中等效果.
- 阿片类药物对抗剂 (纳尔特力,纳尔梅芬) 和托皮拉显示出AUD药物治疗的最一致的证据.
- 药物遗传学方法有希望,但需要更强大的数据来进行常规的临床整合.
结论:
- 纳尔特雷和托皮拉是有效的药物治疗方法,可以减少AUD中的酒精消耗.
- 需要进一步的研究来优化药物治疗策略,包括AUD的剂量,持续时间和组合疗法.
- 改善基于证据的AUD药物治疗的临床利用对于患者的治疗结果至关重要.
更多相关视频
相关概念视频
CNS Depressants: Alcohol and Nicotine
244
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
244
Drug Therapy
69
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
69
Antidepressant Drugs: MAOIs and Other Agents
275
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
275
Depressants
142
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
142
Substance Use Disorders Affecting Sleep
196
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
196
Drug Abuse and Addiction: Pharmacological Phenomena
521
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
521


